The Complete
TRT Guide 2026.

What is low testosterone — and why it matters.

Testosterone is the primary male sex hormone — produced mainly in the testes under the direction of the hypothalamic-pituitary-gonadal (HPG) axis. It governs muscle mass, bone density, fat distribution, red blood cell production, libido, mood, and cognitive function. It is not just a "sex hormone" — it is a master regulator of male physiology.

Hypogonadism is the medical term for chronically low testosterone production. It affects an estimated 13 million American men, though the majority go undiagnosed. It is classified into two categories:

• Primary hypogonadism — the testes fail to produce adequate testosterone despite appropriate hormonal signaling from the brain. Causes include Klinefelter syndrome, testicular injury, chemotherapy, or radiation.
• Secondary hypogonadism — the problem originates in the hypothalamus or pituitary, which fail to send adequate LH and FSH signals to the testes. Causes include obesity, chronic illness, opioid use, stress, and age-related hormonal decline.

Testosterone levels decline naturally with age — approximately 1-2% per year after age 30. For many men, this gradual decline crosses the clinical threshold for hypogonadism in their 40s, 50s, or 60s. But low T is not exclusively an older man's problem — it is increasingly diagnosed in men in their 30s, driven by obesity, chronic stress, poor sleep, and environmental factors including endocrine-disrupting chemicals.

Symptoms of low testosterone — the complete picture.

Low testosterone does not present the same way in every man. Symptoms vary significantly based on the degree of deficiency, how long it has been present, and individual variation in androgen receptor sensitivity. Many men attribute their symptoms to "getting older" or "stress" — and are never tested.

Diagnosing low T — what the numbers mean.

Diagnosis requires both symptoms consistent with hypogonadism AND confirmed low testosterone on blood work. The Endocrine Society recommends measuring testosterone in the morning (7-10 AM) when levels are highest, and confirming with a second test if the first is borderline.

The essential lab panel

Real TRT vs enclomiphene — what Hims won't tell you.

This is the most important section for men who have been researching TRT online and encountered Hims, Ro, or similar platforms. There is a fundamental difference between what ThriveAxis offers and what most online men's health platforms provide — and most platforms are not upfront about it.

When is enclomiphene actually appropriate?

To be fair — enclomiphene is not a bad medication. It has specific, legitimate clinical uses. It is the right choice when:

• A man has secondary hypogonadism driven by a correctable cause (obesity, poor sleep, opioid use) and the goal is to restore natural production
• Fertility preservation is the primary concern — enclomiphene maintains sperm production, while TRT suppresses it
• A younger man wants to try stimulating natural production before committing to exogenous testosterone

What it is not: a replacement for TRT in men who have primary hypogonadism, severe testosterone deficiency, or who have tried natural stimulation approaches without success. And it is definitely not what most men mean when they search "TRT online."

Types of testosterone — choosing the right delivery method.

Testosterone is available in multiple formulations, each with different pharmacokinetics, convenience, and clinical trade-offs. Your ThriveAxis provider recommends the formulation that best suits your lifestyle, absorption profile, and clinical needs.

TRT dosing protocols — what the numbers look like.

TRT dosing is highly individualized. The goal is not to maximize testosterone — it is to achieve optimal levels that resolve symptoms without excessive side effects. Start low, adjust based on labs and clinical response.

Testosterone Cypionate — typical starting protocol

Adjunct medications commonly used with TRT

• HCG (Human Chorionic Gonadotropin) — Mimics LH, maintains testicular function and fertility. Typically 500-1000 IU subcutaneously twice weekly alongside TRT. Prevents testicular atrophy. Essential for men who wish to preserve fertility.
• Anastrozole (Arimidex) — An aromatase inhibitor (AI) that prevents excessive conversion of testosterone to estrogen. Used when estradiol rises above 40 pg/mL on TRT. Typically 0.25-0.5mg twice weekly. Not all men need an AI — your labs determine this.
• Enclomiphene or Clomiphene — Occasionally used post-TRT to help restart natural testosterone production during a discontinuation protocol.

How to start TRT through ThriveAxis.

What to expect on TRT — week by week.

TRT is not an overnight transformation. Different aspects of testosterone's effects appear at different timescales. Patience and consistent monitoring are essential.

Blood work monitoring — why it is non-negotiable.

TRT without regular monitoring is dangerous. Elevated hematocrit, excessive estrogen, PSA changes, and liver values all require regular evaluation. This is not optional — it is the foundation of safe TRT. Any platform that does not require regular monitoring is not practicing responsible medicine.

TRT side effects — and how to manage every one.

Common and manageable

• Elevated estrogen (aromatization) — Testosterone converts to estradiol via aromatase enzyme in fat tissue. Symptoms: water retention, mood swings, gynecomastia (breast tissue development), reduced libido. Management: Anastrozole (AI) if E2 exceeds 40 pg/mL. Not all men need an AI. Labs guide this decision.
• Testicular atrophy — Exogenous testosterone signals the testes to stop natural production, leading to shrinkage. Universal with TRT, though severity varies. Management: HCG co-administration maintains testicular volume and function. Most men on HCG report minimal or no atrophy.
• Elevated hematocrit — As described above. Management: Regular monitoring. If hematocrit exceeds 52%, dose reduction, increased hydration, or therapeutic phlebotomy (blood donation) may be indicated.
• Acne and oily skin — Particularly in men predisposed to acne. More common with higher doses and with topical formulations. Management: Dose optimization. Topical retinoids if needed. Usually improves after the first 3-6 months as the body adjusts.
• Hair loss (DHT acceleration) — TRT increases DHT production, which can accelerate male pattern baldness in genetically predisposed men. Management: Finasteride or minoxidil if hair preservation is a concern. Discuss with your provider before starting.
• Mood swings around injection days — With once-weekly dosing, testosterone peaks at day 2-3 and troughs by day 7 — causing noticeable energy and mood fluctuations. Management: Switch to twice-weekly dosing, which eliminates the peaks and troughs.

Serious risks — rare but require monitoring

• Cardiovascular risk — The evidence on TRT and cardiovascular events is nuanced. The 2023 TRAVERSE trial — the largest TRT cardiovascular outcomes trial — found TRT was non-inferior to placebo for major cardiovascular events. Earlier concerns have largely been addressed by modern data, but men with established cardiovascular disease should discuss risk-benefit carefully with their provider.
• Polycythemia — Dangerously elevated hematocrit requiring intervention. Prevented by monitoring. If hematocrit approaches 55%, dose must be reduced.
• Prostate effects — TRT is contraindicated in men with active prostate cancer. TRT does not cause prostate cancer, but may stimulate existing androgen-sensitive tumors. PSA monitoring before and during TRT is essential. Significant PSA elevation requires urological evaluation before continuing TRT.
• Sleep apnea worsening — TRT can worsen obstructive sleep apnea in predisposed men. If you snore heavily or have diagnosed sleep apnea, discuss this with your provider before starting.

TRT and fertility — what you must know before you start.

This is the conversation that every TRT provider must have before writing the first prescription. If you are not having this conversation, find a different provider.

Exogenous testosterone suppresses the HPG axis — the brain stops sending LH and FSH signals to the testes because it detects adequate circulating testosterone. LH drives testosterone production in the testes; FSH drives sperm production. When both are suppressed, sperm production drops dramatically — often to zero within 3-6 months of TRT initiation.

If you want to have children now or in the future

Tell your ThriveAxis provider at your consultation. This changes your protocol significantly. Options include:

• HCG + TRT combination — HCG mimics LH, maintaining testicular function and sperm production alongside TRT. Most men maintain adequate sperm counts on this protocol. Standard ThriveAxis approach for men who want fertility preservation.
• Enclomiphene or Clomiphene instead of TRT — For men with secondary hypogonadism who prioritize fertility, stimulating natural production is preferable to exogenous testosterone. May be appropriate as a bridge or alternative.
• Sperm banking before starting — For men who may want children in the distant future, banking sperm before initiating TRT is a prudent option. Your provider can refer you to reproductive specialists.

Can fertility return after stopping TRT?

Yes — for most men, sperm production recovers after discontinuing TRT, though it takes time. Recovery typically takes 3-6 months, sometimes longer. Recovery is not guaranteed, particularly after years of TRT without HCG. This is why the conversation before starting matters more than any management after the fact.

Long-term TRT — what decades of data show.

TRT for hypogonadism is increasingly viewed the same way as thyroid replacement or insulin therapy — as ongoing management of a chronic hormonal deficiency rather than a finite treatment course. For men with true hypogonadism, the question is not "how long do I take TRT" but "what is my ongoing management strategy."

Long-term benefits supported by research

• Bone mineral density — Long-term TRT consistently improves and maintains bone density in hypogonadal men, reducing osteoporosis and fracture risk. Effects accumulate over years.
• Metabolic health — Long-term studies show sustained improvements in insulin sensitivity, body composition, and lipid profiles in men on TRT who maintain proper monitoring.
• Cardiovascular outcomes — The TRAVERSE trial (2023) demonstrated cardiovascular safety for TRT in men with hypogonadism and elevated cardiovascular risk. Long-term observational data suggests properly monitored TRT is cardioprotective in hypogonadal men.
• Quality of life — Sustained improvements in energy, mood, sexual function, and cognitive performance are documented in men who remain on TRT long-term.

Stopping TRT — what to expect

If you stop TRT, testosterone levels will drop as exogenous hormone clears (typically 2-4 weeks for cypionate). Your natural production may resume but often returns to pre-TRT levels or below — especially after years of HPG axis suppression. A proper discontinuation protocol with enclomiphene or HCG can help stimulate natural production recovery. Never stop TRT abruptly without provider guidance.

What TRT actually costs in 2026.

TRT FAQ.